These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30851425)

  • 1. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
    Fang Y; Sun B; Wang J; Wang Y
    Gene; 2019 May; 699():37-42. PubMed ID: 30851425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
    Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
    Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis.
    Zhou Q; Zhu Y; Wei X; Zhou J; Chang L; Sui H; Han Y; Piao D; Sha R; Bai Y
    Cell Death Dis; 2016 Oct; 7(10):e2413. PubMed ID: 27735951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer.
    Lee Y; Kim SJ; Choo J; Heo G; Yoo JW; Jung Y; Rhee SH; Im E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFA.
    Lin H; Fang Z; Su Y; Li P; Wang J; Liao H; Hu Q; Ye C; Fang Y; Luo Q; Lin Z; Pan C; Wang F; Zhang ZY
    EBioMedicine; 2017 Apr; 18():62-72. PubMed ID: 28330603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.
    Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W
    Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircN4BP2L2 promotes colorectal cancer growth and metastasis through regulation of the miR-340-5p/CXCR4 axis.
    Yang KD; Wang Y; Zhang F; Luo BH; Feng DY; Zeng ZJ
    Lab Invest; 2022 Jan; 102(1):38-47. PubMed ID: 34326457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
    Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
    Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0056618 promoted cell proliferation, migration and angiogenesis through sponging with miR-206 and upregulating CXCR4 and VEGF-A in colorectal cancer.
    Zheng X; Ma YF; Zhang XR; Li Y; Zhao HH; Han SG
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4190-4202. PubMed ID: 32373955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
    Wang S; Xiao Z; Hong Z; Jiao H; Zhu S; Zhao Y; Bi J; Qiu J; Zhang D; Yan J; Zhang L; Huang C; Li T; Liang L; Liao W; Ye Y; Ding Y
    Cancer Lett; 2018 Dec; 439():78-90. PubMed ID: 30253191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.
    Liang H; Xiao J; Zhou Z; Wu J; Ge F; Li Z; Zhang H; Sun J; Li F; Liu R; Chen C
    Oncogene; 2018 Apr; 37(15):1961-1975. PubMed ID: 29367761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
    Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-1228
    Jia L; Chen J; Xie C; Shao L; Xu Z; Zhang L
    Life Sci; 2017 Jul; 180():9-16. PubMed ID: 28465246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
    Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis.
    Wu B; Zhang L; Yu Y; Lu T; Zhang Y; Zhu W; Song Q; Lv C; Guo J; Tian Y; Deng N
    Cell Death Dis; 2020 May; 11(5):345. PubMed ID: 32393810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.